Free tool

Cell therapy stocks

We cover 21 companies grouped under the Cell therapy theme. The median market value in the group is $21.68M. Across the group, the median move over the past trading day is −0.81%. 29% of the 21 with a 200-day average trade above it. Price change over the past year runs from −85.4% to −14.4% across the middle 80 percent of the group, with a median of −50.4%.

Other lists in this group

Table

21 of 86 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
ATRAAtara Biotherapeutics, Inc.$94.15MMicro cap−24.05%
ACETAdicet Bio, Inc.$83.79MMicro cap−26.01%
ALPSAlps Group Inc$69.85MMicro cap−83.60%
INKTMiNK Therapeutics, Inc.$60.16MMicro cap−26.22%
TCRXTScan Therapeutics, Inc.$50.80MMicro cap−58.43%
TVGNTevogen Inc.$43.63MMicro cap−85.43%
DTSQDT Cloud Star Acquisition Corporation$41.39MMicro cap+8.42%
CCELCryo-Cell International, Inc.$34.67MMicro cap−3.19%
ESLAEstrella Immunopharma, Inc.$31.75MMicro cap−22.34%
SVA.TOSernova Biotherapeutics Inc$29.93MMicro cap−42.11%
LGVNLongeveron Inc.$21.68MMicro cap−14.44%
NCELNewcelX Ltd.$19.52MMicro cap−84.77%
PLURPluri Inc.$17.91MMicro cap−69.17%
SNTISenti Biosciences Holdings, Inc.$12.03MMicro cap−75.23%
INABIN8bio, Inc.$11.68MMicro cap−48.03%
GDTCCytoMed Therapeutics Limited$11.06MMicro cap−50.41%
CELZCreative Medical Technology Holdings, Inc.$7.85MMicro cap−63.27%
PMCBPharmaCyte Biotech, Inc.$5.80MMicro cap−44.28%
ERNAErnexa Therapeutics Inc.$5.70MMicro cap−85.93%
BRTXBioRestorative Therapies, Inc.$5.67MMicro cap−86.10%
MBIOMustang Bio, Inc.$4.24MMicro cap−63.40%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse